Skip to content

VLTO · Veralto

10 filings

10-Q

VLTO 10-Q Quarterly Reports

Veralto - 10 quarterly reports

Filing record · 2023–202610-K310-Q108-K28

2026-Q3
Veralto Quarterly Report for Q3 Ended Oct 2, 2026
Veralto Corporation's 10-Q for the quarter ended October 2, 2026 reports third-quarter sales of $1,509 million, up from $1,404 million a year earlier, with net earnings of $253 million versus $239 million. For the nine months, sales were $4,405 million (versus $4,107 million) and net earnings were $748 million (versus $686 million), with diluted EPS of $3.03 compared with $2.74. The company states that core sales rose 5.1% in the quarter and 3.8% year to date, with acquisitions and currency also contributing to reported growth. Operating profit margin fell to 19.7% in the quarter from 23.2%, driven by a tax indemnification reduction tied to the Danaher separation, restructuring charges under the 2026 Cost Optimization Program, and acquisition-related costs. The balance sheet expanded during the period. Goodwill rose to $3,200 million and other intangible assets to $820 million, reflecting the In-Situ and GlobalVision acquisitions. Cash and equivalents were $1,785 million at quarter end, and total debt was $2,920 million. The company refinanced its $700 million 2026 Notes with a $725 million issuance of 2032 Notes and issued $250 million of commercial paper to help fund the Cleanwater1 acquisition, which closed on October 5, 2026 for $465 million. Shareholders received $96 million in dividends and the company repurchased $523 million of stock year to date under a $750 million program, with $227 million remaining. Operating cash flow for the nine months was $845 million, up from $766 million. Management states it expects steady sequential sales in Product Quality & Innovation and continued growth in Water Quality, while noting ongoing uncertainty from tariffs and conflict in the Middle East.
Oct 30, 2026
2026-Q3
Veralto Quarterly Report for Q3 Ended Jul 3, 2026
Veralto Corporation's second-quarter 2026 Form 10-Q (quarter ended July 3, 2026) shows sales of $1.47 billion for the three-month period, up from $1.37 billion a year earlier, with the company reporting a 7.6% increase in total sales and 4.2% core sales growth. Net earnings rose to $241 million from $222 million, though operating profit margin fell to 21.4% from 22.8%, driven mainly by restructuring charges tied to the 2026 Cost Optimization Program and higher SG&A. For the six-month period, sales were $2.90 billion and net earnings were $495 million, with diluted EPS of $2.00. The balance sheet expanded materially during the period. Total assets reached $8.56 billion, up from $7.69 billion at December 31, 2025, as the company completed the acquisitions of In-Situ, Inc. (about $426 million net of cash acquired) and GlobalVision (about $195 million net of cash acquired). Total debt rose to $3.38 billion from $2.67 billion after the company issued $725 million of 4.85% senior notes due 2032 in June 2026. Cash and cash equivalents stood at $2.12 billion. Capital return activity was significant. The company repurchased about 5 million shares for roughly $434 million in the six-month period, leaving $317 million remaining under its $750 million repurchase program, and declared a regular quarterly dividend of $0.13 per share.
Jul 29, 2026
2026-Q2
Veralto Quarterly Report for Q2 Ended Apr 3, 2026
Veralto Corporation reported net earnings of $254 million for the three months ended April 3, 2026, up from $225 million a year earlier. Sales rose to $1,422 million from $1,332 million, a total sales increase of 6.7% that included 1.9% core sales growth. Diluted EPS was $1.02 compared with $0.90. Operating profit was $338 million, and operating profit margin was 23.8% versus 24.2%, with the filing citing higher labor costs, In-Situ and GlobalVision transaction costs, and an inventory fair value adjustment from the In-Situ acquisition as headwinds. Water Quality core sales grew 3.8%, while Product Quality & Innovation core sales declined 1.0%. Capital deployment was significant in the quarter. Veralto completed the In-Situ acquisition on January 22, 2026 for approximately $426 million net of cash acquired, and repurchased about 3 million shares for approximately $300 million, leaving $450 million remaining under its $750 million repurchase program. Cash and cash equivalents fell to $1,431 million from $2,031 million at year-end 2025, and total debt was $2,662 million principal, including $700 million of 5.50% notes due September 2026 that the company says it is currently evaluating alternatives to address. On April 27, 2026, the Board approved a 2026 Restructuring Program with total expected charges of approximately $85 million to $105 million, of which approximately $65 million to $85 million are expected in 2026. The company also completed the GlobalVision acquisition on April 7, 2026 for approximately CAD $270 million net of cash acquired, after the quarter ended.
Apr 29, 2026
2025-Q3
Veralto Quarterly Report for Q3 Ended Oct 3, 2025
Veralto Corporation's Form 10-Q for the quarter ended October 3, 2025 reports third-quarter sales of $1,404 million, up from $1,314 million a year earlier, and nine-month sales of $4,107 million versus $3,848 million. Net earnings were $239 million for the quarter (diluted EPS $0.95, versus $0.88) and $686 million for the nine months (diluted EPS $2.74, versus $2.43). The company attributes the growth primarily to core sales increases driven by higher volumes and positive pricing, with core sales growth of 5.1% for the quarter and 5.9% for the nine months. Operating profit was $326 million in the quarter and $961 million year to date, with operating margins of 23.2% and 23.4%, respectively. The balance sheet strengthened over the period. Cash and cash equivalents rose to $1,775 million from $1,101 million at year-end 2024, and total debt was $2,672 million, including a $700 million current portion due in 2026. Nine-month operating cash flow was $766 million, compared with $590 million in the prior-year period. Management reports that the company paid $82 million in dividends during the nine months and declared a quarterly dividend of $0.11 per share payable October 31, 2025. The filing also notes that no amounts were outstanding under the credit facility or commercial paper program as of October 3, 2025. Management cites positive secular growth drivers in Water Quality, particularly in North America, and expects steady demand in consumer-packaged goods markets for Product Quality & Innovation. The company continues to monitor tariffs and trade policy changes, and it reports no material changes to its risk factors from the 2024 Form 10-K.
Oct 29, 2025
2025-Q3
Veralto Quarterly Report for Q3 Ended Jul 4, 2025
Veralto Corporation's Form 10-Q for the quarter ended July 4, 2025 reports second-quarter sales of $1,371 million, up 6.4% from $1,288 million a year earlier, with core sales growth of 4.8%. Net earnings were $222 million (diluted EPS $0.89) versus $203 million (diluted EPS $0.81). For the six months, sales were $2,703 million, up 6.6%, and net earnings were $447 million (diluted EPS $1.79) versus $387 million. Management attributes the earnings increase primarily to higher sales from volume growth and positive pricing actions. Operating profit margin was 22.8% for the quarter, down from 23.2%, which management attributes partly to acquisition and divestiture dilution and strategic initiative costs. Cash generation strengthened: operating cash flow for the six months was $496 million, up from $366 million, and cash and cash equivalents rose to $1,559 million from $1,101 million at year-end 2024. Long-term debt increased to $2,672 million from $2,599 million, with the company stating it was in compliance with all debt covenants and had no amounts outstanding under its credit facility or commercial paper program. A regular quarterly dividend of $0.11 per share was declared, payable July 31, 2025. By segment, Water Quality sales rose 6.2% in the quarter and Product Quality & Innovation sales rose 6.8%. Management expects continued secular growth in municipal and industrial water markets, particularly in North America, and steady demand in consumer-packaged goods markets, while continuing to evaluate the impact of tariffs and trade policy changes.
Jul 28, 2025
2025-Q2
Veralto Quarterly Report for Q2 Ended Apr 4, 2025
Veralto Corporation (VLTO) reported its first-quarter 2025 results for the three-month period ended April 4, 2025, in this Form 10-Q filed April 30, 2025. Sales rose to $1,332 million from $1,246 million in the prior-year period, and the filing states total sales growth of 6.9%, with core sales growth of 7.8% (excluding a 1.3% currency headwind and a 0.4% acquisitions/divestitures benefit). Gross profit was $805 million (60.4% gross margin, versus 60.0%), operating profit was $322 million (24.2% operating margin, versus 23.5%), and net earnings were $225 million, or $0.90 diluted EPS, compared with $184 million, or $0.74 diluted EPS, a year earlier. The filing attributes the earnings increase mainly to higher sales from volume and pricing, and notes that three extra days in the fiscal first quarter benefited year-over-year comparisons. Both segments grew. Water Quality sales rose to $794 million from $749 million, with operating profit of $198 million, and Product Quality & Innovation sales rose to $538 million from $497 million, with operating profit of $146 million. Operating cash flow increased to $157 million from $115 million, and cash and cash equivalents ended at $1,239 million, up from $1,101 million at December 31, 2024. Long-term debt was $2,630 million. Management expects positive secular growth drivers in industrial water markets and steady demand in consumer-packaged goods, while noting it is evaluating the impact of tariffs and trade policy changes. The filing adds a new risk factor on U.S. tariffs and related foreign countermeasures. The quarter's balance sheet and cash flow were stable: total assets were $6,645 million, the company paid $27 million in dividends ($0.11 per share declared for the quarter), and it reported no amounts outstanding under its credit facility or commercial paper program as of April 4, 2025.
Apr 30, 2025
2024-Q3
Veralto Quarterly Report for Q3 Ended Sep 27, 2024
Veralto Corporation's Form 10-Q for the quarter ended September 27, 2024 shows third-quarter sales of $1.314 billion, up from $1.255 billion a year earlier, with net earnings of $219 million versus $205 million and diluted EPS of $0.88 versus $0.83. For the nine months, sales were $3.848 billion (versus $3.733 billion) and net earnings were $606 million, down from $639 million, with diluted EPS of $2.43 versus $2.59. The filing attributes the nine-month earnings decline to standalone public company costs, interest expense following the Separation from Danaher, sales and marketing growth investments, and a net loss on product line dispositions. Management reports core sales growth of 4.6% for the quarter and 3.4% year to date, and gross profit margin of 59.6% for the quarter versus 57.6% a year earlier. Cash and cash equivalents rose to $1.267 billion from $762 million at year-end 2023, and long-term debt was $2.639 billion. Operating cash flow was $590 million for the nine months, down from $700 million, reflecting cash interest payments of $137 million and cash tax payments of $209 million. The company declared a regular quarterly dividend of $0.09 per share, and the filing states that substantially all private notes were exchanged for registered notes in the exchange offer that expired September 3, 2024. After the quarter end, on October 4, 2024, the company completed its acquisition of Information Exchange Holdings, Inc., the holding company that owns TraceGains, for $350 million, subject to customary post-closing adjustments. The company describes the acquisition as complementing its Product Quality & Innovation segment, specifically the packaging and color solutions business.
Oct 24, 2024
2024-Q2
Veralto Quarterly Report for Q2 Ended Jun 28, 2024
Veralto Corporation's Form 10-Q for the quarter ended June 28, 2024 reports sales of $1,288 million for the three-month period, up 2.8% from $1,253 million a year earlier, and $2,534 million for the six-month period, up 2.3% from $2,478 million. Core sales grew 3.8% in the quarter and 2.8% year-to-date, with price increases contributing 2.0% and 2.1% to sales growth. Gross profit margin rose to 60.1% in the quarter from 57.8%, while SG&A expenses rose to 32.1% of sales from 30.2%, which the filing attributes to sales and marketing growth initiatives and the costs of operating as a stand-alone company. Net earnings were $203 million for the quarter, down from $209 million, and diluted EPS was $0.81 versus $0.85. Six-month net earnings were $387 million, down from $434 million, and diluted EPS was $1.55 versus $1.76. The balance sheet strengthened in cash, with cash and cash equivalents of $1,043 million at June 28, 2024, up from $762 million at December 31, 2023. Long-term debt was $2,615 million, and the company had no amounts outstanding under its credit facility or commercial paper program. Net interest expense was $30 million for the quarter and $58 million for the six months, reflecting indebtedness incurred in September 2023 in connection with the separation from Danaher Corporation, completed September 30, 2023. Operating cash flow was $366 million for the six months, down from $457 million, driven by cash interest payments of $57 million and cash tax payments of $142 million. The company declared a regular quarterly dividend of $0.09 per share payable July 31, 2024. The filing states that the company expects positive secular growth drivers in industrial markets, particularly in North America, steady demand at municipalities, and a steady, modest recovery in consumer packaged goods markets over the balance of 2024. The filing also records a $15 million loss on the divestiture of a Water Quality product line during the six months.
Jul 26, 2024
2024-Q1
Veralto Quarterly Report for Q1 Ended Mar 29, 2024
Veralto Corporation (VLTO) reported unaudited results for the three-month period ended March 29, 2024 in this Form 10-Q. Sales rose 1.8% to $1,246 million from $1,225 million, and gross profit increased to $747 million from $708 million, with gross margin of 60.0% versus 57.8%. Net earnings declined to $184 million from $225 million, driven by higher operating expenses, standalone public company costs, interest expense following the Separation from Danaher, and a $15 million loss on the sale of a product line. Diluted EPS was $0.74 compared with $0.91 a year earlier. The Water Quality segment grew sales 2.7% to $749 million and operating profit rose to $181 million, while Product Quality & Innovation sales were essentially flat at $497 million with operating profit of $133 million. Management expects positive secular growth drivers in industrial water markets, steady municipal demand, and a modest recovery in consumer-packaged goods markets as the year progresses. Cash and cash equivalents were $827 million at quarter end against $2,618 million of long-term debt. Operating cash flow fell to $115 million from $156 million, reflecting $57 million of cash interest and $32 million of cash taxes, and the company paid $22 million in dividends, declaring a regular quarterly dividend of $0.09 per share.
Apr 24, 2024
2023-Q3
Veralto Quarterly Report for Q3 Ended Sep 29, 2023
Veralto Corporation (VLTO) filed this Quarterly Report on Form 10-Q for the quarter ended September 29, 2023, its first 10-Q following its separation from Danaher Corporation. The separation was completed on September 30, 2023 through a pro rata distribution of Veralto common stock to Danaher stockholders, and Veralto's shares began regular-way trading on the New York Stock Exchange on October 2, 2023. The financial statements are combined carve-out statements derived from Danaher's historical records. In connection with the separation, Veralto issued approximately $2.1 billion of U.S. dollar senior unsecured notes and €500 million of euro notes, with proceeds of about $2.6 billion paid to Danaher as consideration for the contributed net assets. For the three-month period ended September 29, 2023, sales were $1,255 million, up from $1,219 million, and net earnings were $205 million, down from $218 million, with the company citing higher operating expenses as it prepared to operate as a stand-alone company. For the nine-month period, sales were $3,733 million versus $3,622 million and net earnings were $639 million versus $629 million. Operating profit margin was 21.8% in the third quarter versus 23.4% a year earlier, and 22.9% year-to-date versus 22.6%. Core sales grew 1.0% in the quarter and 3.0% year-to-date, with China a notable drag in high-growth markets. The filing states that management expects weakness in consumer-packaged goods demand to affect Product Quality & Innovation core sales in the fourth quarter, and broad weakness in China to affect both segments. The company also intends to initiate a quarterly cash dividend of $0.09 per common share beginning after the quarter ending December 31, 2023, subject to Board approval.
Oct 26, 2023